These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations. Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843 [TBL] [Abstract][Full Text] [Related]
4. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels. Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494 [TBL] [Abstract][Full Text] [Related]
5. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. Tani S; Matsumoto M; Nagao K; Hirayama A J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623 [TBL] [Abstract][Full Text] [Related]
6. Women have a larger and less atherogenic low density lipoprotein particle size than men. Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495 [TBL] [Abstract][Full Text] [Related]
7. Atherogenicity of triglyceride-rich lipoproteins. Krauss RM Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808 [TBL] [Abstract][Full Text] [Related]
8. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Tornvall P; Karpe F; Carlson LA; Hamsten A Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399 [TBL] [Abstract][Full Text] [Related]
9. Statins do not decrease small, dense low-density lipoprotein. Choi CU; Seo HS; Lee EM; Shin SY; Choi UJ; Na JO; Lim HE; Kim JW; Kim EJ; Rha SW; Park CG; Oh DJ Tex Heart Inst J; 2010; 37(4):421-8. PubMed ID: 20844614 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Kwiterovich PO Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Chait A; Brazg RL; Tribble DL; Krauss RM Am J Med; 1993 Apr; 94(4):350-6. PubMed ID: 8475928 [TBL] [Abstract][Full Text] [Related]
12. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study. van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441 [TBL] [Abstract][Full Text] [Related]
14. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249 [TBL] [Abstract][Full Text] [Related]
15. LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow. Packard CJ Curr Med Res Opin; 1996; 13(7):379-90. PubMed ID: 8862937 [TBL] [Abstract][Full Text] [Related]
16. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Krauss RM Am J Med; 1998 Jul; 105(1A):58S-62S. PubMed ID: 9707269 [TBL] [Abstract][Full Text] [Related]
17. Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates. Stevenson SC; Sawyer JK; Rudel LL Arterioscler Thromb; 1992 Jan; 12(1):28-40. PubMed ID: 1731856 [TBL] [Abstract][Full Text] [Related]
18. [Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease]. Afanasieva OI; Utkina EA; Artemieva NV; Ezhov MV; Adamova IY; Pokrovsky SN Kardiologiia; 2016 Jun; 56(6):5-11. PubMed ID: 28290840 [TBL] [Abstract][Full Text] [Related]
19. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Sharrett AR; Patsch W; Sorlie PD; Heiss G; Bond MG; Davis CE Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665 [TBL] [Abstract][Full Text] [Related]